Narrative Review: Terapi Kortikosteroid Pada Pasien COVID-19 dengan Komorbiditas Diabetes Melitus
-
Novia Ariani Dewi
*
Universitas Gadjah Mada, Yogyakarta,
Indonesia
- Tri Murti Andayani Universitas Gadjah Mada, Yogyakarta, Indonesia
- Ika Trisnawati Universitas Gadjah Mada, Yogyakarta, Indonesia (*) Corresponding Author
Abstract
COVID-19 is a respiratory disease caused by SARS-CoV-2, a corona virus that was discovered at the end of 2019. Diabetes mellitus (DM) is the second highest comorbidities in Indonesia of COVID-19 patients. One of the treatments for COVID-19 patients is corticosteroids. Commonly used corticosteroids are dexamethasone, methylprednisolone, and hydrocortisone. This study aims to determine the effect of corticosteroid therapy in COVID-19 patients with DM comorbidities so that it can be a source of information and a reference in the management of therapy in patients. This research is a narrative review using literature from the science databases Cochrane, PubMed and Science Direct. Literature search used the keywords COVID-19, diabetes, and corticosteroids. The results of the literature screening obtained 16 study articles that met the inclusion criteria. The conclusion of this narrative review study is that the recommended corticosteroid therapy for COVID-19 patients is dexamethasone. Administering corticosteroids to COVID-19 patients with comorbid DM can increase the incidence of hyperglycemia, especially at high doses and in the long term, thereby worsening the patient's prognosis, causing new onset diabetes, and increasing the need for insulin doses.
Downloads
References
Abdi, A., Jalilian, M., Sarbarzeh, P. A., & Vlaisavljevic, Z. (2020). Diabetes and COVID-19: A systematic review on the current evidences. Diabetes Research and Clinical Practice, 166. Retrieved 22 June 2023 from https://doi.org/10.1016/J.DIABRES.2020.108347
Alessi, J., De Oliveira, G. B., Schaan, B. D., & Telo, G. H. (2020). Dexamethasone in the era of COVID-19: friend or foe? An essay on the effects of dexamethasone and the potential risks of its inadvertent use in patients with diabetes. Diabetology & Metabolic Syndrome, 12(1), 1–11. Retrieved 22 June 2023 from https://doi.org/10.1186/S13098-020-00583-7
Brooks, D., Schulman-Rosenbaum, R., Griff, M., Lester, J., & Low Wang, C. C. (2022). Glucocorticoid-Induced Hyperglycemia Including Dexamethasone-Associated Hyperglycemia in COVID-19 Infection: A Systematic Review. Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 28(11), 1166–1177. Retrieved 22 June 2023 from https://doi.org/10.1016/J.EPRAC.2022.07.014
CDC. (2021). Disease of the Week - COVID-19’, Centers for Disease Control and Prevention. Retrieved 22 June 2023, from https://www.cdc.gov/health-topics.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fdotw%2Fcovid-19%2Findex.html
Ceriello, A. (2020). Hyperglycemia and COVID-19: What was known and what is really new? Diabetes Research and Clinical Practice, 167. Retrieved 22 June 2023 from https://doi.org/10.1016/J.DIABRES.2020.108383
Chen, Z., Yin, X., Tan, X., Wang, J., Jiang, N., Tian, M., … Gong, Y. (2022). Effectiveness of Systemic Corticosteroids Therapy for Nonsevere Patients With COVID-19: A Multicenter, Retrospective, Longitudinal Cohort Study. Value in Health : The Journal of the International Society for Pharmacoeconomics and Outcomes Research, 25(5), 709–716. Retrieved 22 June 2023 from https://doi.org/10.1016/J.JVAL.2021.12.013
Dastenae, Z. H., Bahadori, A., Dehghani, M., Asadi-Samani, M., Izadi, I., & Shahraki, H. R. (2022). Comparison of the effect of intravenous dexamethasone and methylprednisolone on the treatment of hospitalized patients with COVID-19: a randomized clinical trial. International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases, 122, 659–664. Retrieved 22 June 2023 from https://doi.org/10.1016/J.IJID.2022.07.019
Deng, F., Gao, D., Ma, X., Guo, Y., Wang, R., Jiang, W., & Gong, S. (2021). Corticosteroids in diabetes patients infected with COVID-19. Irish Journal of Medical Science, 190(1), 29–31. Retrieved 22 June 2023 from https://doi.org/10.1007/S11845-020-02287-3
DINKES DIY. (2022). Yogyakarta Tanggap COVID-19’, Informasi Covid-19 Daerah Istimewa Yogyakarta. Retrieved 22 June 2023, from https://corona.jogjaprov.go.id/index.php/map
Douin, D. J., Krause, M., Williams, C., Tanabe, K., Fernandez-Bustamante, A., Quaye, A. N., … Bartels, K. (2022). Corticosteroid Administration and Impaired Glycemic Control in Mechanically Ventilated COVID-19 Patients. Seminars in Cardiothoracic and Vascular Anesthesia, 26(1), 32–40. Retrieved 22 June 2023 from https://doi.org/10.1177/10892532211043313
El mezzeoui, S., El aidouni, G., Merbouh, M., El Kaouini, A., Aftiss, F. Z., berrichi, S., … Housni, B. (2021). Dexamethasone or methylprednisolone therapy in covid-19 pneumonia: A retrospective and comparative study of 513 cases. Annals of Medicine and Surgery (2012), 70. Retrieved 22 June 2023 from https://doi.org/10.1016/J.AMSU.2021.102858
Elamari, S., Motaib, I., Zbiri, S., Elaidaoui, K., Chadli, A., & Elkettani, C. (2020). Characteristics and outcomes of diabetic patients infected by the SARS-CoV-2. Pan African Medical Journal, 37. Retrieved from https://doi.org/10.11604/pamj.2020.37.32.25192
Fatima, S. A., Asif, M., Khan, K. A., Siddique, N., & Khan, A. Z. (2020). Comparison of efficacy of dexamethasone and methylprednisolone in moderate to severe covid 19 disease. Annals of Medicine and Surgery (2012), 60, 413–416. Retrieved 22 June 2023 from https://doi.org/10.1016/J.AMSU.2020.11.027
Hodgens, A., & Sharman, T. (2023). Corticosteroids - PubMed. Retrieved 22 June 2023, from https://pubmed.ncbi.nlm.nih.gov/32119499/
Hwang, J. L., & Weiss, R. E. (2014). Steroid-induced diabetes: a clinical and molecular approach to understanding and treatment. Diabetes/Metabolism Research and Reviews, 30(2), 96–102. Retrieved from https://doi.org/10.1002/dmrr.2486
Karyono, D. R., & Wicaksana, A. L. (2020). Current prevalence, characteristics, and comorbidities of patients with COVID-19 in Indonesia. Journal of Community Empowerment for Health, 3(2), 77. Retrieved from https://doi.org/10.22146/jcoemph.57325
Lancet. (2023). Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. Retrieved 22 June 2023 from https://doi.org/10.1016/S0140-6736(23)00510-X
Lee, M. H., Wong, C., Ng, C. H., Yuen, D. C. W., Lim, A. Y. L., & Khoo, C. M. (2021). Effects of hyperglycaemia on complications of COVID ‐19: A meta‐analysis of observational studies. Diabetes, Obesity and Metabolism, 23(1), 287–289. Retrieved from https://doi.org/10.1111/dom.14184
Liu, Z., Li, X., Fan, G., Zhou, F., Wang, Y., Huang, L., … Cao, B. (2021). Low-to-moderate dose corticosteroids treatment in hospitalized adults with COVID-19. Clinical Microbiology and Infection : The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases, 27(1), 112–117. Retrieved 22 June 2023 from https://doi.org/10.1016/J.CMI.2020.09.045
Mondal, S., DasGupta, R., Lodh, M., Gorai, R., Choudhury, B., Hazra, A. K., & Ganguly, A. (2021). Predictors of new-onset diabetic ketoacidosis in patients with moderate to severe COVID-19 receiving parenteral glucocorticoids: A prospective single-centre study among Indian type 2 diabetes patients. Diabetes Metab Syndr, 15(3), 795–801. Retrieved 22 June 2023 from https://doi.org/10.1016/J.DSX.2021.03.022
Moreno, A., Vargas, C., Azocar, F., Villarroel, F., Cofré, M., Oppliger, H., … Zamora, F. (2021). Steroids and mortality in non‐critically ill COVID‐19 patients: a propensity score‐weighted study in a Chilean cohort. International Journal of Infectious Diseases, 112, 124–129. Retrieved from https://doi.org/10.1016/j.ijid.2021.09.038
Nassar, M., Daoud, A., Nso, N., Medina, L., Ghernautan, V., Bhangoo, H., … Misra, A. (2021). Diabetes Mellitus and COVID-19: Review Article. Diabetes & Metabolic Syndrome, 15(6). Retrieved 22 June 2023 from https://doi.org/10.1016/J.DSX.2021.102268
NIH. (2022). COVID-19 Treatment Guidelines. Retrieved 22 June 2023, from https://www.covid19treatmentguidelines.nih.gov/
Parise, R., Deruiter, J., Ren, J., Govindarajulu, M., Ramesh, S., Nadar, R. M., … Dhanasekaran, M. (2022). Impact of COVID-19 therapy on hyperglycemia. Https://Doi.Org/10.1177/14791641221095091, 19(2). Retrieved 22 June 2023 from https://doi.org/10.1177/14791641221095091
Patel, V. K., Shirbhate, E., Patel, P., Veerasamy, R., Sharma, P. C., & Rajak, H. (2021). Corticosteroids for treatment of COVID-19: effect, evidence, expectation and extent. Beni-Suef University Journal of Basic and Applied Sciences, 10(1), undefined-undefined. Retrieved 22 June 2023 from https://doi.org/10.1186/S43088-021-00165-0
Rhou, Y. J. J., Hor, A., Wang, M., Wu, Y.-F., Jose, S., Chipps, D. R., & Cheung, N. W. (2022). Dexamethasone-induced hyperglycaemia in COVID-19: Glycaemic profile in patients without diabetes and factors associated with hyperglycaemia. Diabetes Research and Clinical Practice, 194, 110151. Retrieved from https://doi.org/10.1016/j.diabres.2022.110151
Rios, S. S., Chen, A. C. R., Chen, J. R., de Resende, C. N., & Júnior, E. A. (2022). Coronavirus 2019 disease: Are corticosteroids the key treatment? A retrospective case-control study in Brazil. Annals of Medicine & Surgery, 82. Retrieved from https://doi.org/10.1016/j.amsu.2022.104746
Roncon, L., Zuin, M., Rigatelli, G., & Zuliani, G. (2020). Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor short-term outcome. Journal of Clinical Virology : The Official Publication of the Pan American Society for Clinical Virology, 127. Retrieved 22 June 2023 from https://doi.org/10.1016/J.JCV.2020.104354
Sterne, J. A. C., Murthy, S., Diaz, J. V., Slutsky, A. S., Villar, J., Angus, D. C., … Marshall, J. C. (2020). Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis. JAMA, 324(13), 1330–1341. Retrieved 22 June 2023 from https://doi.org/10.1001/JAMA.2020.17023
Tran, V. T., Mahévas, M., Bani-Sadr, F., Robineau, O., Perpoint, T., Perrodeau, E., … Lescure, F. X. (2021). Corticosteroids in patients hospitalized for COVID-19 pneumonia who require oxygen: observational comparative study using routine care data. Clinical Microbiology and Infection : The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases, 27(4), 603–610. Retrieved 22 June 2023 from https://doi.org/10.1016/J.CMI.2020.11.035
Wang, Z., Du, Z., & Zhu, F. (2020). Glycosylated hemoglobin is associated with systemic inflammation, hypercoagulability, and prognosis of COVID-19 patients. Diabetes Research and Clinical Practice, 164, 108214. Retrieved 22 June 2023 from https://doi.org/10.1016/J.DIABRES.2020.108214
WHO. (2022). WHO Coronavirus (COVID-19) Dashboard | WHO Coronavirus (COVID-19) Dashboard With Vaccination Data. Retrieved 22 June 2023, from https://covid19.who.int/
Zamarrón, E., Carpio, C., Villamañán, E., Álvarez-Sala, R., Borobia, A. M., Gómez-Carrera, L., … Prados, M. C. (2023). Impact of systemic corticosteroids on length of hospitalization among patients with COVID-19. Farmacia Hospitalaria : Organo Oficial de Expresion Cientifica de La Sociedad Espanola de Farmacia Hospitalaria, 47(2). Retrieved 22 June 2023 from https://doi.org/10.1016/J.FARMA.2023.02.001
Bila bermanfaat silahkan share artikel ini
Berikan Komentar Anda terhadap artikel Narrative Review: Terapi Kortikosteroid Pada Pasien COVID-19 dengan Komorbiditas Diabetes Melitus
Pages: 231-244
Copyright (c) 2023 Novia Ariani Dewi, Tri Murti Andayani, Ika Trisnawati
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under Creative Commons Attribution 4.0 International License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (Refer to The Effect of Open Access).
